151 related articles for article (PubMed ID: 38044793)
1. Self-Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma.
Li Y; Zhao Q; Zhu X; Zhou L; Song P; Liu B; Tian D; Chen Q; Zhou J; Deng G
CNS Neurosci Ther; 2024 Apr; 30(4):e14528. PubMed ID: 38044793
[TBL] [Abstract][Full Text] [Related]
2. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
3. Magnetic targeting of paclitaxel-loaded poly(lactic-
Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
[TBL] [Abstract][Full Text] [Related]
4. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
6. Ursolic acid nanoparticles for glioblastoma therapy.
Li Y; Zhao L; Zhao Q; Zhou Y; Zhou L; Song P; Liu B; Chen Q; Deng G
Nanomedicine; 2023 Jun; 50():102684. PubMed ID: 37100267
[TBL] [Abstract][Full Text] [Related]
7. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma.
Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P
J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944
[TBL] [Abstract][Full Text] [Related]
9. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
10. Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model.
Wiwatchaitawee K; Ebeid K; Quarterman JC; Naguib Y; Ali MY; Oliva C; Griguer C; Salem AK
Bioconjug Chem; 2022 Nov; 33(11):1957-1972. PubMed ID: 35041398
[TBL] [Abstract][Full Text] [Related]
11. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
12. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
13. Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.
Sandbhor P; Goda J; Mohanty B; Gera P; Yadav S; Chekuri G; Chaudhari P; Dutt S; Banerjee R
Drug Deliv Transl Res; 2023 Feb; 13(2):608-626. PubMed ID: 36245060
[TBL] [Abstract][Full Text] [Related]
14. Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.
Zhang W; Li C; Shen C; Liu Y; Zhao X; Liu Y; Zou D; Gao Z; Yue C
Drug Deliv; 2016 Sep; 23(7):2575-2580. PubMed ID: 26056720
[TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
16. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
17. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
[TBL] [Abstract][Full Text] [Related]
18. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.
Ruan C; Liu L; Lu Y; Zhang Y; He X; Chen X; Zhang Y; Chen Q; Guo Q; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):85-96. PubMed ID: 29872625
[TBL] [Abstract][Full Text] [Related]
19. Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study.
Schiariti MP; Restelli F; Ferroli P; Benetti A; Berenzi A; Ferri A; Ceserani V; Ciusani E; Cadei M; Finocchiaro G; Pessina A; Parati E; Pallini R; Alessandri G
Cytotherapy; 2017 Jun; 19(6):721-734. PubMed ID: 28434806
[TBL] [Abstract][Full Text] [Related]
20. Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery.
Hu L; Li M; Zhang Z; Shen Y; Guo S
Int J Pharm; 2018 Dec; 553(1-2):510-521. PubMed ID: 30308274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]